Bank Of Montreal Supernus Pharmaceuticals, Inc. Transaction History

Bank Of Montreal

$197 Billion
Q2 2024

A detailed history of Bank Of Montreal transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 116,322 shares of SUPN stock, worth $3.58 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

116,322

Previous 7,234 1507.99%

Holding current value

$3.58 Million

Previous $246,000 1164.63%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$25.99 - $33.85 $2.84 Million - $3.69 Million	109,088 Added 1507.99%	116,322 $3.11 Million
Q1 2024 May 13, 2024	BUY	$27.11 - $35.17 $3,876 - $5,029	143 Added 2.02%	7,234 $246,000
Q4 2023 Feb 08, 2024	SELL	$22.72 - $29.68 $462,170 - $603,750	-20,342 Reduced 74.15%	7,091 $205,000
Q3 2023 Nov 01, 2023	BUY	$27.57 - $32.91 $529,123 - $631,608	19,192 Added 232.88%	27,433 $756,000
Q2 2023 Aug 02, 2023	SELL	$29.91 - $38.73 $71,006 - $91,945	-2,374 Reduced 22.36%	8,241 $247,000
Q1 2023 Jun 13, 2024	BUY	$34.93 - $42.03 $38,842 - $46,737	1,112 Added 15.37%	8,346 $302,000
Q4 2022 Feb 01, 2023	BUY	$31.09 - $37.88 $138,195 - $168,376	4,445 Added 72.04%	10,615 $378,000
Q3 2022 Nov 10, 2022	SELL	$28.79 - $35.41 $47,273 - $58,143	-1,642 Reduced 21.02%	6,170 $210,000
Q2 2022 Aug 11, 2022	SELL	$25.33 - $34.25 $207,300 - $280,302	-8,184 Reduced 51.16%	7,812 $227,000
Q1 2022 May 12, 2022	BUY	$28.51 - $32.9 $42,422 - $48,955	1,488 Added 10.26%	15,996 $519,000
Q4 2021 Feb 11, 2022	SELL	$26.37 - $34.22 $98,913 - $128,359	-3,751 Reduced 20.54%	14,508 $437,000
Q3 2021 Nov 12, 2021	SELL	$23.54 - $31.39 $5,531 - $7,376	-235 Reduced 1.27%	18,259 $492,000
Q2 2021 Aug 12, 2021	BUY	$26.72 - $33.19 $494,159 - $613,815	18,494 New	18,494 $605,000

Others Institutions Holding SUPN

# of Institutions

255

Shares Held

59.2M

Call Options Held

47.9K

Put Options Held

13.1K

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.64B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account